Barclays’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.75M | Buy |
274,830
+274,413
| +65,806% | +$2.74M | ﹤0.01% | 2017 |
|
|
2025
Q1 | $37K | Sell |
417
-195
| -32% | -$17.3K | ﹤0.01% | 3953 |
|
|
2024
Q4 | $57K | Buy |
612
+70
| +13% | +$6.52K | ﹤0.01% | 3924 |
|
|
2024
Q3 | $39K | Buy |
542
+410
| +311% | +$29.5K | ﹤0.01% | 3964 |
|
|
2024
Q2 | $8K | Sell |
132
-93
| -41% | -$5.64K | ﹤0.01% | 3995 |
|
|
2024
Q1 | $233K | Sell |
225
-215
| -49% | -$223K | ﹤0.01% | 3259 |
|
|
2023
Q4 | $348K | Buy |
440
+330
| +300% | +$261K | ﹤0.01% | 3216 |
|
|
2023
Q3 | $52K | Buy |
110
+13
| +13% | +$6.15K | ﹤0.01% | 3576 |
|
|
2023
Q2 | $58K | Sell |
97
-38
| -28% | -$22.7K | ﹤0.01% | 3607 |
|
|
2023
Q1 | $94K | Buy |
135
+24
| +22% | +$16.7K | ﹤0.01% | 3564 |
|
|
2022
Q4 | $113K | Buy |
111
+100
| +909% | +$102K | ﹤0.01% | 3391 |
|
|
2022
Q3 | $6K | Sell |
11
-104
| -90% | -$56.7K | ﹤0.01% | 4321 |
|
|
2022
Q2 | $63K | Sell |
115
-50
| -30% | -$27.4K | ﹤0.01% | 3645 |
|
|
2022
Q1 | $105K | Buy |
+165
| New | +$105K | ﹤0.01% | 3643 |
|